Skip to menu Skip to content Skip to footer

An Open Label, Multicentre, Phase One Study Incorporating Early Application of CAR T cells for Primary Refractory Aggressive Lymphoma (2019-2025)

Experts

Associate Professor Colm Keane

Principal Research Fellow
Frazer Institute
Faculty of Medicine
Colm Keane